Biotronik announced the presentation of data from the iliac arm of the BIOFLEX-I clinical trial at the Cardiovascular Research Technologies (CRT) conference in Washington, D.C. The BIOFLEX-I trial is designed to support U.S. Food and Drug Administration (FDA) approval of the Astron self-expanding nitinol stent to treat patients suffering from common iliac or external iliac artery disease.

AliveCor Inc. announced the launch of the latest version of the AliveECG app, which instantly detects when an electrocardiogram (ECG) is either normal or unreadable.

Fujifilm Medical Systems U.S.A. Inc. will demonstrate the latest version of Synapse Cardiovascular 6.0 and Synapse 3-D 4.1 at the American College of Cardiology (ACC) 64th Annual Scientific Session & Expo on March 14 -16 in San Diego, California.

Corindus Vascular Robotics Inc. announced it has initiated a clinical trial of its CorPath System in peripheral vascular interventions. The study is currently enrolling patients at the Medical University of Graz in Graz, Austria, and is led by Prof. Marianne Brodmann, M.D., a leading researcher with the university’s Division of Angiology, in combination with Prof. Hannes Deutschmann, M.D., of the Medical University of Graz Department of Radiology, and study chairman, Ehtisham Mahmud, M.D., director, Sulpizio Cardiovascular Center-Medicine, UC San Diego.

Bracco Imaging, through its business unit Bracco Injeneering SA, announced the availability of its EmpowerCTA+, an advanced engineering contrast injection system.

The American College of Cardiology (ACC) has launched version 2.0 of their Guideline Clinical App. With the addition of the healthy lifestyle and obesity guidelines, the app now contains the full set of clinical prevention guidelines released by ACC/American Heart Association in 2013.

Subscribe Now